Advertisement

Journal of NeuroVirology

, Volume 23, Issue 4, pp 558–567 | Cite as

Association of long-term patterns of depressive symptoms and attention/executive function among older men with and without human immunodeficiency virus

  • Nicole M. ArmstrongEmail author
  • Pamela J. Surkan
  • Glenn J. Treisman
  • Ned C. Sacktor
  • Michael R. Irwin
  • Linda A. Teplin
  • Ron Stall
  • Eileen M. Martin
  • James T. Becker
  • Cynthia Munro
  • Andrew J. Levine
  • Lisa P. Jacobson
  • Alison G. Abraham
Article

Abstract

Older HIV-infected men are at higher risk for both depression and cognitive impairments, compared to HIV-uninfected men. We evaluated the association between longitudinal patterns of depressive symptoms and attention/executive function in HIV-infected and HIV-uninfected men aged 50+ years to understand whether HIV infection influenced the long-term effect of depression on attention/executive function. Responses to the Center for Epidemiologic Studies—Depression scale and attention/executive function tests (Trail Making Test Part B and Symbol Digit Modalities Test) were collected semiannually from May 1986 to April 2015 in 1611 men. Group-based trajectory models, stratified by HIV status, were used to identify latent patterns of depressive symptoms and attention/executive function across 12 years of follow-up. We identified three depression patterns for HIV-infected and HIV-uninfected men (rare/never 50.0 vs. 60.6%, periodically depressed 29.6 vs. 24.5%, chronic high 20.5 vs.15.0%, respectively) and three patterns of attention/executive function for HIV-infected and HIV-uninfected men (worst-performing 47.4 vs. 45.1%; average 41.9 vs. 47.0%; best-performing 10.7 vs. 8.0%, respectively). Multivariable logistic regression models were used to assess associations between depression patterns and worst-performing attention/executive function. Among HIV-uninfected men, those in the periodically depressed and chronic high depressed groups had higher odds of membership in the worst-performing attention/executive function group (adjusted odds ratio [AOR] = 1.45, 95% CI 1.04, 2.03; AOR = 2.25, 95% CI 1.49, 3.39, respectively). Among HIV-infected men, patterns of depression symptoms were not associated with patterns of attention/executive function. Results suggest that HIV-uninfected, but not HIV-infected, men with chronic high depression are more likely to experience a long-term pattern of attention/executive dysfunction.

Keywords

Depression Human immunodeficiency virus Aging Attention/executive function 

Notes

Acknowledgments

The authors would like to thank all MACS participants and Alden Gross and Ms. Natalie Kelso for their expertise.

Compliance with ethical standards

The study protocol was approved at all collaborating institutions’ IRBs, and participants provided written informed consent.

Funding

This study was supported by the National Institutes of Health (1R03MH10396-01). An additional source of support for MACS included the Center for AIDS Research, Johns Hopkins University (P30AI094189). NMA was supported by fellowship from the Epidemiology and Biostatistics of Aging Training Grant (5T32AG000247).

Data in this manuscript were collected by the Multicenter AIDS Cohort Study (MACS): MACS (principal investigators): Johns Hopkins University Bloomberg School of Public Health (Joseph Margolick), U01-AI35042; Northwestern University (Steven Wolinsky), U01-AI35039; University of California, Los Angeles (Roger Detels), U01-AI35040; University of Pittsburgh (Charles Rinaldo), U01-AI35041; and the Center for Analysis and Management of MACS, Johns Hopkins University Bloomberg School of Public Health (Lisa Jacobson), UM1-AI35043. The MACS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH). Targeted supplemental funding for specific projects was also provided by the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute on Deafness and Communication Disorders (NIDCD). MACS data collection is also supported by UL1-TR001079 (JHU ICTR) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.

Role of funder/sponsor

The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH), Johns Hopkins ICTR, or NCATS. The MACS website is located at http://aidscohortstudy.org/.

Conflict of interest

The authors declare that they have no conflicts of interest.

Supplementary material

13365_2017_527_MOESM1_ESM.docx (13 kb)
Table S1 (DOCX 13 kb).
13365_2017_527_MOESM2_ESM.docx (13 kb)
Table S2 (DOCX 12 kb).
13365_2017_527_MOESM3_ESM.docx (13 kb)
Table S3 (DOCX 13 kb).
13365_2017_527_MOESM4_ESM.docx (13 kb)
Table S4 (DOCX 12 kb).
13365_2017_527_MOESM5_ESM.docx (23 kb)
Figure S1 (DOCX 23 kb).

References

  1. Albert M, Moss M, Tanzi R, Jones K (2001) Preclinical prediction of AD using neuropsychological tests. JINS 7:631–639PubMedGoogle Scholar
  2. Almeida OP, Alfonso H, Flicker L, Hankey GJ, Norman PE (2012) Cardiovascular disease, depression and mortality: the Health in Men Study. Am J Geriatr Psychiatry 20:433–440CrossRefPubMedGoogle Scholar
  3. Andreescu C, Chang C, Mulsant B, Ganguli M (2008) Twelve-year depressive symptom trajectories and their predictors in a community sample of older adults. Int Psychogeriatr 20:221–236CrossRefPubMedPubMedCentralGoogle Scholar
  4. Ariyo AA, Haan M, Tangen CM, Rutledge JC, Cushman M, Dobs A, Furberg CD, Group CHSCR (2000) Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Circulation 102:1773–1779CrossRefPubMedGoogle Scholar
  5. Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K (2006) Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry 63:273–279CrossRefPubMedGoogle Scholar
  6. Becker J, Kingsley L, Mullen J, Cohen B, Martin E, Miller E, Ragin A, Sacktor N, Selnes O, Visscher B, for Multicenter AIDS Cohort Study (2009) Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology 73:1292–1299CrossRefPubMedPubMedCentralGoogle Scholar
  7. Becker J, Kingsley LA, Molsberry S, Reynolds S, Aronow A, Levine AJ, Martin E, Miller EN, Munro CA, Ragin A, Sacktor N, Selnes OA (2014) Cohort profile: recruitment cohorts in the neuropsychological substudy of the Multicenter AIDS Cohort Study. Int J Epidemiol: 1–11Google Scholar
  8. Broadhead W, Blazer D, George L, Tee C (1990) Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA 264:2524–2528CrossRefPubMedGoogle Scholar
  9. Butters M, Whyte E, Nebes R, Begley A, Dew M, Mulsant B, Zmuda M, Bhalla R, Meltzer C, Pollock B, Reynolds C, Becker J (2004) The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry 61:587–595CrossRefPubMedGoogle Scholar
  10. Campos L, Guimaraes M, Remien R (2008) Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil. AIDS Behav 14Google Scholar
  11. Ciesla JA, Roberts JE (2001) Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 158:725–730CrossRefPubMedGoogle Scholar
  12. Cole M, Margolick J, Cox C, Li X, Selnes O, Martin E, Becker J, Aronow H, Cohen B, Sacktor N, Miller E, for Multicenter AIDS Cohort Study (2007) Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals. Neurology 69:2213–2220CrossRefPubMedGoogle Scholar
  13. Corrigan JD, Hinkeldey NS (1987) Relationships between parts A and B of the Trail Making Test. J Clin Psychol 43:402–409CrossRefPubMedGoogle Scholar
  14. Dawes S, Suarez P, Casey CY, Cherner M, Marcotte TD, Letendre S, Grant I, Heaton RK, the HNRC Group (2008) Variable patterns of neuropsychological performance in HIV-1 infection. J Clin Exp Neuropsychol 30:613–626CrossRefPubMedPubMedCentralGoogle Scholar
  15. Drane DL, Yuspeh RL, Huthwaite JS, Klingler LK (2002) Demographic characteristics and normative observations for derived-trail making test indices. Cogn Behav Neurol 15:39–43Google Scholar
  16. Ganguli M (2009) Depression, cognitive impairment and dementia: why should clinicians care about the web of causation? Indian J Psychiatry 51:S29–S34PubMedPubMedCentralGoogle Scholar
  17. Gonzalez JS, Batchelder AW, Psaros C, Safren SA (2011) Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr 58 doi: 10.1097/QAI.0b013e31822d490a
  18. Goodkin K, Wilkie F, Concha M, Hinkin C, Symes S, Baldewicz T, Asthana D, Fujimura R, Lee D, Mv Z, Khamis I, Shapshak P, Eisdorfer C (2001) Aging and neuro-AIDS conditions and the changing spectrum of HIV-1-associated morbidity and mortality. J Clin Epidemiol 54:S35–S43CrossRefPubMedGoogle Scholar
  19. Graziane JA, Beer JC, Snitz BE, Chang C-CH, Ganguli M (2016) Dual trajectories of depression and cognition: a longitudinal population-based study. Am J Geriatr Psychiatry 24:364–373CrossRefPubMedGoogle Scholar
  20. Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, Berti A, Rossi E, Roverato A, Palella F (2011) Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 53:1120–1126CrossRefPubMedGoogle Scholar
  21. Heaton R, Marcotte T, Mindt M, Sadek J, Moore D, Bentley H, McCutchan J, Reicks C, Grant I (2004) The impact of HIV-associated neuropsychological impairment on everyday functioning. JINS 10:317–331PubMedGoogle Scholar
  22. Heaton R, Clifford D, Franklin D, Woods S, Ake C, Vaida F, Ellis R, Letendre S, Marcotte T, Atkinson J, Rivera-Mindt M, Vigil O, Taylor M, Collier A, Marra C, Gelman B, McArthur J, Morgello S, Simpson D, McCutchan J, Abramson I, Gamst A, Fennema-Notestine C, Jernigan T, Wong J, Grant I, For the CHARTER Group (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087–2096CrossRefPubMedPubMedCentralGoogle Scholar
  23. Heaton R, Franklin D, Ellis R, McCutchan J, Letendre S, LeBlanc S, Corkran S, Duarte N, Clifford D, Woods S, Collier A, Marra C, Morgello S, Mindt MR, Taylor M, Marcotte T, Atkinson JH, Wolfson T, Gelman B, McArthur J, Simpson D, Abramson I, Gamst A, Fennema-Notestine C, Jernigan T, Wong J, Grant I, For the CHARTER and HNRC Groups (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neuro-Oncol 17:3–16Google Scholar
  24. Horberg M, Silverberg M, Hurley L, Towner W, Klein D, Bersoff-Matcha S, Weinberg W, Antoniskis D, Mogyoros M, Dodge W, Dobrinich R, Quesenberry C, Kovach D (2008) Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr 47:384–390CrossRefPubMedGoogle Scholar
  25. Ironson G, O’Cleirigh C, Fletcher M, Laurenceau J, Balbin E, Klimas N, Schneiderman N, Solomon G (2005) Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med 67:1013–1021CrossRefPubMedPubMedCentralGoogle Scholar
  26. Jin J, Grimmig B, Izzo J, Brown L, Hudson C, Smith A, Tan J, Bickford P, Giunta B (2016) HIV non-nucleoside reverse transcriptase inhibitor efavirenz reduces neural stem cell proliferation in vitro and in vivo. Cell Transplant 25:1967–1977CrossRefPubMedGoogle Scholar
  27. Jones B, Nagin D (2007) Advances in group-based trajectory modeling and an SAS procedure for estimating them. Sociol Methods Res 35:542–571CrossRefGoogle Scholar
  28. Jones B, Nagin D, Roeder K (2001) A SAS procedure based on mixture models for estimating developmental trajectories. Sociol Methods Res 29:374–393CrossRefGoogle Scholar
  29. Kaslow R, Ostrow D, Detels R, Phair J, Polk B, Jr CR (1987) The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 126:310–318CrossRefPubMedGoogle Scholar
  30. Kiecolt-Glaser JK, Glaser R (2002) Depression and immune function. J Psychosom Res 53:873–876CrossRefPubMedGoogle Scholar
  31. Kommer TN, Comijs H, Aartsen M, Huisman M, Deeg D, Beekman A (2013) Depression and cognition: how do they interrelate in old age? Am J Geriatr Psychiatry 21:398–410CrossRefPubMedGoogle Scholar
  32. Lyness JM, Noel TK, Cox C, King DA, Conwell Y, Caine ED (1997) Screening for depression in elderly primary care patients: a comparison of the Center for Epidemiologic Studies-Depression Scale and the Geriatric Depression Scale. Arch Intern Med 157:449–454CrossRefPubMedGoogle Scholar
  33. Mahy M, Autenreith CS, Stanecki K, Wynd S (2014) Increasing trends in HIV prevalence among people aged 50 years and older: evidence from estimates and survey data. AIDS 28:S453–S459CrossRefPubMedPubMedCentralGoogle Scholar
  34. Murphy R, Hagaman A, Reinders I, Steeves J, Newman A, Rubin S, Satterfield S, Kritchevsky S, Yaffe K, Ayonayon H, Nagin D, Simonsick E, Penninx B, Harris T, For the Health ABC Study (2015) Depressive trajectories and risk of disability and mortality in older adults: longitudinal findings from the Health, Aging, and Body Composition Study. J Gerontol A Biol Sci Med Sci: 1–8Google Scholar
  35. Nagin D, Odgers C (2010) Group-based trajectory modeling in clinical research. Ann Rev Clin Psychol 6:109–138. doi: 10.1146/annurev.clinpsy.121208.131413.: 109-138 CrossRefGoogle Scholar
  36. Nagin D, Tremblay R (2001) Analyzing developmentary trajectories of distinct but related behaviors: a group-based method. Psychol Methods 6:18–34CrossRefPubMedGoogle Scholar
  37. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 30 Dec 2016.
  38. Petersen RC, Doody R, Kurz A et al (2001) Current concepts in mild cognitive impairment. Arch Neurol 58:1985–1992CrossRefPubMedGoogle Scholar
  39. Plassman BL, Williams JW Jr, Burke J, Holsinger T, Benjamin S (2010) Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med 153:182–193CrossRefPubMedGoogle Scholar
  40. R Core Team (2015) R: a language and environment for statistical computing. R Foundation for Statistical Computing, ViennaGoogle Scholar
  41. Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRefGoogle Scholar
  42. Rawlings AM, Sharrett AR, Schneider ALC, Coresh J, Albert M, Couper D, Griswold M, Gottesman RF, Wagenknecht LE, Windham BG, Selvin E (2014) Diabetes in midlife and cognitive change over 20 years: the Atherosclerosis Risk in Communities Neurocognitive Study. Ann Intern Med 161:785–793CrossRefPubMedPubMedCentralGoogle Scholar
  43. Reger M, Welsh R, Razani J, Martin D, Boone K (2002) A meta-analysis of the neuropsychological sequelae of HIV infection. JINS 8:410–424PubMedGoogle Scholar
  44. Reitan R (1958) Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 8:271–276CrossRefGoogle Scholar
  45. Rosenberg PB, Mielke MM, Xue Q-L, Carlson MC (2010) Depressive symptoms predict incident cognitive impairment in cognitive healthy older women. Am J Geriatr Psychiatry 18:204–211CrossRefPubMedPubMedCentralGoogle Scholar
  46. Sachdev P, Lipnicki D, Crawford J, Reppermund S, Kochan N, Trollor J, Draper B, Slavin M, Kang K, Lux O, Mather K, Brodaty H, the Memory and Ageing Study Team (2012) Risk profiles of subtypes of mild cognitive impairment: the Sydney Memory and Ageing Study. JAGS 60:24–33CrossRefGoogle Scholar
  47. Sacktor N, Bacellar H, Hoover D, Nance-Sproson T, Selnes O, Miller E, Pan GD, Kleeberger C, Brown A, Saah A, McArthur J (1996) Psychomotor slowing in HIV infection: a predictor of dementia, AIDS, and death. J Neuro-Oncol 2:404–410Google Scholar
  48. Sacktor N, Skolasky RL, Cox C, Selnes O, Becker JT, Cohen B, Martin E, Miller EN (2010) Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatus. J Neuro-Oncol 16:335–341Google Scholar
  49. Saczynski JS, Beiser A, Seshadri S, Auerbach S, Wolf P, Au R (2010) Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology 75:35–41CrossRefPubMedPubMedCentralGoogle Scholar
  50. Salthouse TA (1996) The processing-speed theory of adult age differences in cognition. Psychol Rev 103:403–428CrossRefPubMedGoogle Scholar
  51. Sanchez-Cubillo I, Perianez J, Adrover-Roig D, Rodriguez-Sanchez J, Rios-Lago M, Tirapu J, Barcelo F (2009) Construct validity of the Trail Making Test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J Int Neuropsychol Soc 15:438CrossRefPubMedGoogle Scholar
  52. SAS Institute Inc (2002-2004) SAS 9.1.3. SAS Institute Inc., CaryGoogle Scholar
  53. Savetsky J, Sullivan L, Clarke J, Stein M, Samet J (2001) Evolution of depressive symptoms in human immunodeficiency virus-infected patients entering primary care. J Nerv Ment Dis 189:76–83CrossRefPubMedGoogle Scholar
  54. Selnes OA, Miller EN (1994) Development of a screening battery for HIV-related cognitive impairment: the MACS experience. In: Grant I, Martin A (eds) Neuropsychology of HIV infection. Oxford University Press, Inc., New York, pp 176–187Google Scholar
  55. Smith A (ed) (1968) The symbol-digit modalities test: a neuropsychologic test of learning and other cerebral disorders. Special Child Publications, SeattleGoogle Scholar
  56. Snowden MB, Atkins DC, Steinman LE, Bell JF, Bryant LL, Copeland C, Fitzpatrick AL (2015) Longitudinal association of dementia and depression. Am J Geriatr Psychiatry 23:897–905CrossRefPubMedGoogle Scholar
  57. StataCorp (2013) Stata Statistical Software: Release 13. StataCorp LP, College StationGoogle Scholar
  58. Substance Abuse and Mental Health Services Administration (2011) The treatment of depression in older adults: depression and older adults: key issues. Services DoHaH, (ed). Center for Mental Health Services, Substance Abuse and Mental Health Services Administration, US Department of Health and Human Services. US Department of Health and Human Services AIDS.gov
  59. Vance D, Mugavero M, Willig J, Raper J, Saag M (2011) Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life. J Assoc Nurses AIDS Care 22:17–25CrossRefPubMedGoogle Scholar
  60. Walensky R, Paltiel A, Losina E, Mercincavage L, Schackman B, Sax P, Weinstein M, Freedberg K (2006) The survival benefits of AIDS treatment in the United States. J Infect Dis 194:11–19CrossRefPubMedGoogle Scholar
  61. Wendelken LA, Valcour V (2012) Impact of HIV and aging on neuropsychological function. J Neuro-Oncol 18:256–263Google Scholar

Copyright information

© Journal of NeuroVirology, Inc. 2017

Authors and Affiliations

  • Nicole M. Armstrong
    • 1
    Email author
  • Pamela J. Surkan
    • 2
  • Glenn J. Treisman
    • 3
  • Ned C. Sacktor
    • 4
  • Michael R. Irwin
    • 5
    • 6
  • Linda A. Teplin
    • 7
  • Ron Stall
    • 8
  • Eileen M. Martin
    • 9
  • James T. Becker
    • 10
  • Cynthia Munro
    • 4
  • Andrew J. Levine
    • 11
  • Lisa P. Jacobson
    • 1
  • Alison G. Abraham
    • 1
    • 12
  1. 1.Departments of EpidemiologyJohns Hopkins University Center on Aging and Health, Johns Hopkins Bloomberg School of Public HealthBaltimoreUSA
  2. 2.International HealthJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA
  3. 3.Departments of Psychiatry and Behavioral SciencesJohns Hopkins University School of MedicineBaltimoreUSA
  4. 4.NeurologyJohns Hopkins University School of MedicineBaltimoreUSA
  5. 5.Cousins Center for Psychoneuroimmunology, UCLA Semel Institute for NeuroscienceUCLA David Geffen School of MedicineLos AngelesUSA
  6. 6.Departments of Psychiatry and Biobehavioral SciencesUCLA David Geffen School of MedicineLos AngelesUSA
  7. 7.Departments of Psychiatry and Behavioral Sciences and Medicine: Infectious DiseasesFeinberg School of MedicineChicagoUSA
  8. 8.Departments of Behavioral and Community HealthUniversity of Pittsburgh Medical CenterPittsburghUSA
  9. 9.Department of PsychiatryRush University Medical CenterChicagoUSA
  10. 10.Psychiatry, Psychology, and NeurologyUniversity of Pittsburgh Medical CenterPittsburghUSA
  11. 11.NeurologyUCLA David Geffen School of MedicineLos AngelesUSA
  12. 12.Department of OphthalmologyJohns Hopkins School of MedicineBaltimoreUSA

Personalised recommendations